PDL BioPharma (United States)

316 papers and 26.5k indexed citations i.

About

In recent decades, authors affiliated with PDL BioPharma (United States) have published 316 papers, which have received a total of 26.5k indexed citations. Scholars at this organization have produced 150 papers in Molecular Biology, 105 papers in Radiology, Nuclear Medicine and Imaging and 90 papers in Immunology on the topics of Monoclonal and Polyclonal Antibodies Research (102 papers), Glycosylation and Glycoproteins Research (41 papers) and Cell Adhesion Molecules Research (40 papers). Their work is cited by papers focused on Molecular Biology (14.5k citations), Immunology (6.5k citations) and Oncology (5.8k citations). Authors at PDL BioPharma (United States) collaborate with scholars in United States, Germany and Japan and have published in prestigious journals including Nature, Science and Cell. Some of PDL BioPharma (United States)'s most productive authors include William A. Kuziel, Naoya Tsurushita, Ellen L. Berg, J. Yun Tso and Cary Queen.

In The Last Decade

Fields of papers published by authors at PDL BioPharma (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with PDL BioPharma (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at PDL BioPharma (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at PDL BioPharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at PDL BioPharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PDL BioPharma (United States) more than expected).

Rankless by CCL
2025